Fundraising Fox
/People
Sign in

Morgan Hunter

Investor

Investment Manager at BioMedPartners

Zurich, Switzerland

Find your path to Morgan

192 people in our graph can introduce you to Morgan.

Sign up to see every warm intro you have to Morgan

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Morgan. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

About

Joined Biomed in 2022 with a background in scientific innovation and early entrepreneurship. Previously developed the business case for the ETH Zurich spin-off Emuna Therapeutics. Holds a Doctor of Sciences from ETH Zurich.

Contact· self-published, not guessed

Experience

  1. BiomedVCInvestment Managercurrent2022 — presentBasel, Switzerland
  2. NXI Therapeutics AGBoard Observercurrent2026 — presentBasel, Switzerland
  3. OmnilinX TherapeuticsBoard Observercurrent2026 — presentMunich, Germany
  4. T-CURX GmbHBoard Observercurrent2025 — presentWürzburg, Germany
  5. iDEL Therapeutics GmbHBoard Observercurrent2025 — presentDortmund, Germany
  6. Salvina TherapeuticsBoard Observercurrent2024 — presentZürich, Switzerland
  7. Dimericon TherapeuticsBoard Observercurrent2023 — presentHorgen, Switzerland
  8. Venture KickJury Membercurrent2026 — presentSchlieren, Switzerland
  9. ETH ZürichEmuna Therapeutics: Innosuisse Innovation Project Leader & SNF BRIDGE Proof of Concept Fellow2019 — 2022Zurich, Switzerland
  10. ETH ZürichResearch Scientist: Doctoral & Postdoctoral Researcher2014 — 2019Zurich, Switzerland

Skills & more

  • Financial Modeling & Valuation Analyst — Corporate Finance Institute
  • Innosuisse Business Creation Biotech — Venturelab

From Morgan's professional profile.

Colleagues at BioMedPartners

Aristotelis Nastos
Managing Partner at BioMedPartners
Claudia Ulbrich
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
David Urech
Venture Partner at BioMedPartners
Kiran Dallenbach
Partner at BioMedPartners
Marianna Feretzaki
Senior Associate at BioMedPartners
Markus Hosang
Managing Partner at BioMedPartners
Mattias Ivarsson
Entrepreneur in Residence at BioMedPartners

Frequently asked questions

Who is Morgan Hunter?
Joined Biomed in 2022 with a background in scientific innovation and early entrepreneurship. Previously developed the business case for the ETH Zurich spin-off Emuna Therapeutics. Holds a Doctor of Sciences from ETH Zurich.
Where does Morgan Hunter work?
Morgan Hunter is Investment Manager at BioMedPartners.
Where did Morgan Hunter go to school?
Morgan Hunter studied at ETH Zürich (Doctor of Sciences (Dr. Sc. ETH Zurich)); Rhodes University (Master of Science (MSc), Biochemistry); Rhodes University (Bachelor of Science Honours (BSc Hons), Biotechnology).

Same school

Shared employers

Also worked at iDEL Therapeutics GmbH1

Aristotelis NastosManaging Partner at BioMedPartners